Bountiful, UT, United States of America

Nyall London

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2011-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Nyall London: Innovator in Vascular Research

Introduction

Nyall London is a prominent inventor based in Bountiful, UT (US). He has made significant contributions to the field of vascular research, particularly in the development of methods and compositions aimed at inhibiting vascular permeability and pathologic angiogenesis. With a total of 2 patents, his work has the potential to impact various medical conditions related to vascular health.

Latest Patents

Nyall London's latest patents focus on compositions and methods for inhibiting vascular permeability. The first patent describes compounds, compositions, and methods that are effective in inhibiting vascular permeability and pathologic angiogenesis. This includes pharmaceutical compositions that can be utilized in treating conditions induced by factors such as VEGF, bFGF, and thrombin. The second patent similarly addresses compositions and methods for treating ocular pathologic angiogenesis and vascular permeability, emphasizing the importance of these innovations in medical treatments.

Career Highlights

Nyall London is affiliated with the University of Utah Research Foundation, where he continues to advance his research in vascular health. His work is characterized by a commitment to developing effective treatments for diseases related to vascular permeability and angiogenesis.

Collaborations

Some of his notable coworkers include Dean Li and Christopher Jones, who contribute to the collaborative efforts in research and development within the foundation.

Conclusion

Nyall London is a dedicated inventor whose work in vascular research is paving the way for innovative treatments. His patents reflect a deep understanding of the complexities of vascular health and the potential for pharmaceutical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…